Evaluation of arrival viral respiratory vaccine treatment on health outcomes in low- to moderate-risk feedlot steers
American Association of Bovine Practitioners Conference Proceedings · 28.04.2026 · 58 (2) · 227
DOI: 10.21423/aabppro20259411 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Association of Bovine Practitioners Conference Proceedings, online erschienen am 28.04.2026. Verfasst von M.E. Theurer und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Respiratory viral vaccines are used for prevention of bovine respiratory disease (BRD). A total of 6,260 beef steers were used to compare the health outcomes of different arrival vaccine programs. Compared were BOVIGENTM Platinum 3 Vaccine (P3), BOVIGEN™ Platinum 5 Vaccine (P5), and Bovi-Shield GOLD® 5 (B5).
Zitieren
APA
Theurer, M., Fox, J., McCarty, T., Newberry, J., & Payot, F. (2026). Evaluation of arrival viral respiratory vaccine treatment on health outcomes in low- to moderate-risk feedlot steers. American Association of Bovine Practitioners Conference Proceedings, 58(2), 227. https://doi.org/10.21423/aabppro20259411
Vancouver
Theurer M, Fox J, McCarty T, Newberry J, Payot F. Evaluation of arrival viral respiratory vaccine treatment on health outcomes in low- to moderate-risk feedlot steers. American Association of Bovine Practitioners Conference Proceedings. 2026;58(2):227. doi:10.21423/aabppro20259411
BibTeX
@article{Theurer2026,
author = {Theurer, M.E. and Fox, J.T. and McCarty, T.M. and Newberry, J.R. and Payot, F.},
title = {Evaluation of arrival viral respiratory vaccine treatment on health outcomes in low- to moderate-risk feedlot steers},
journal = {American Association of Bovine Practitioners Conference Proceedings},
year = {2026},
volume = {58},
number = {2},
pages = {227},
doi = {10.21423/aabppro20259411}
}
EUVIMED